Hydrofarm Holdings Group Announces Third Quarter 2025 Results

Rhea-AI Summary

Hydrofarm (Nasdaq: HYFM) reported Q3 2025 results: net sales $29.4M (down 33.3% YoY), gross profit $3.4M (11.6% margin vs 19.4% prior year) and adjusted gross profit $5.5M (18.8% vs 24.3%).

Net loss was $16.4M or $(3.51) per diluted share; Adjusted EBITDA $(4.4)M. Free cash flow was $(0.2)M, improving by $5.1M year-over-year. Cash was $10.7M with ~$4M available on the revolver and a $114.5M term loan principal outstanding as of Sept 30, 2025.

Operational actions include consolidation of two U.S. manufacturing facilities (expected to generate an incremental $2M annual savings) and additional cost-saving actions with $4M line-of-sight. Bill Toler will resume CEO duties effective Dec 1, 2025. Full-year 2025: Adjusted gross profit margin ~20% and capital expenditures $2M or less.

Positive

• Free cash flow improved by $5.1M year-over-year
• Adjusted SG&A reduced to $9.9M, a 7.4% improvement
• Estimated incremental cost savings of $2M from facility consolidation
• Line-of-sight for additional annual cost savings of $4M
• Company reaffirmed full‑year adjusted gross profit margin of ~20%

Negative

• Net sales declined 33.3% to $29.4M
• Gross profit margin fell to 11.6% from 19.4% prior year
• Net loss widened to $16.4M (diluted loss $(3.51) per share)
• Adjusted EBITDA was negative $(4.4)M
• Liquidity constrained with $10.7M cash and ~$4M revolver availability

Insights

Financial results analyst

Q3 shows sharp revenue decline, wider losses, but cost cuts and cash improvements temper near‑term risk.

Net sales fell 33.3% to $29.4 million and GAAP net loss widened to $16.4 million, driven by a 32.2% volume/mix decline and lower manufacturing throughput. Adjusted Gross Profit Margin dropped to 18.8% and Adjusted EBITDA moved to negative $4.4 million, directly reflecting lower sales and production inefficiencies.

The company reported sequential improvements in operating cash use and a $5.1 million year‑over‑year free cash flow improvement, plus continued SG&A reductions (13th consecutive quarter of year‑over‑year cuts). Key near‑term items to watch include execution of the manufacturing consolidation (savings estimated at $2 million incremental), the additional $4 million of identified annual cost savings, and compliance with debt covenants given $10.7 million cash and $114.5 million term loan principal as of September 30, 2025.

Leadership and operations specialist

CEO transition and factory consolidation signal active remediation, but timing and execution risk remain material.

Effective December 1, 2025, the Executive Chairman resumes the CEO role, which concentrates responsibility for operational turnaround and cost‑saving execution under an experienced board leader. Management highlights portfolio rationalization, SKU and inventory reductions, and a targeted consolidation of two U.S. plants, which management says should yield incremental annual savings of $2 million plus another $4 million identified.

These actions are credible steps to restore margins but depend on fast, clean consolidation and stable demand; monitor completion of facility consolidation over the next few quarters, realized run‑rate savings, and any one‑time charges that could affect near‑term liquidity. The leadership change and the company's reiterated full‑year ~20% adjusted gross profit margin expectation frame the immediate operational priorities through the remainder of 2025.

Announces CEO Transition

SHOEMAKERSVILLE, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its third quarter ended September 30, 2025.

Comparison of Third Quarter vs. Prior Year Period:

• Net sales decreased to $29.4 million compared to $44.0 million.
• Gross Profit Margin decreased to 11.6% of net sales compared to 19.4%.
• Adjusted Gross Profit Margin⁽¹⁾ decreased to 18.8% of net sales compared to 24.3%.
• SG&A expense and Adjusted SG&A⁽¹⁾ expense decreased by 6.8% and 7.4%, respectively.
• Net loss increased to $16.4 million compared to $13.1 million.
• Adjusted EBITDA⁽¹⁾ of $(4.4) million compared to less than $0.1 million.
• Cash used in operating activities and Free Cash Flow⁽¹⁾ improved $4.4 million and $5.1 million, respectively.
  

^{(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.}

John Lindeman, Chief Executive Officer of Hydrofarm, said, "In the third quarter we achieved our best quarterly proprietary brand sales mix of 2025, consistent with our strategy of focusing sales efforts on our higher-margin products. This performance was aided both by heightened investments in certain proprietary products and the previously announced restructuring of our product portfolio. Despite this sales mix improvement, lower manufacturing production volumes hindered our Adjusted Gross Profit Margin in the quarter. To address this issue, we are taking actions to consolidate our two remaining U.S. manufacturing facilities, an activity expected to be completed over the next few quarters, which should generate an estimated $2 million in annual cost savings incremental to the $3 million originally announced last quarter. In addition, we have line of sight and are taking action against further estimated annual cost savings of $4 million. During the quarter, we delivered 7.4% of Adjusted SG&A expense savings, representing our 13^th consecutive quarter of meaningful year-over-year expense reductions and continuing our strong track record of disciplined cost management. We are on track with the restructuring plan announced last quarter, demonstrated by the significant inventory and SKU reductions we completed in the third quarter of this year. We also generated a significant $5.1 million year-over-year improvement in free cash flow in the third quarter while continuing to execute on our strategic roadmap and position the business to better drive high quality revenue streams, improved profitability, and strengthen our financial position. We are focused on what we can control and will remain disciplined in our cost-management as we aim to improve our proprietary brand performance and enhance long-term value for our stockholders."

CEO Transition

Effective December 1, 2025, Bill Toler, Executive Chairman of the Board, is resuming the position of Chief Executive Officer of Hydrofarm. Mr. Lindeman will remain with the Company through December 1, 2025, to ensure a smooth transition. Mr. Toler has served as Hydrofarm’s Chairman of the Board of Directors since January 1, 2019, and previously served as the Company’s Chief Executive Officer from January 1, 2019 until January 1, 2025. Mr. Toler will continue to serve on the Board in the role of Chairman.

“I want to thank John for his dedicated leadership and valuable contributions to Hydrofarm,” said Mr. Toler. “We wish him well in his future endeavors. I am excited to return to the CEO role and remain fully committed to Hydrofarm’s success and restoring the company to profitability, building on the significant progress we’ve made.”

Third Quarter 2025 Financial Results

Net sales decreased 33.3% to $29.4 million compared to $44.0 million in the prior year period. This was due to a 32.2% decline in volume/mix of products sold primarily related to industry oversupply and a 1.1% decrease in price.

Gross Profit decreased to $3.4 million, or 11.6% of net sales, compared to $8.5 million, or 19.4% of net sales, in the prior year period. Adjusted Gross Profit⁽¹⁾ decreased to $5.5 million, or 18.8% of net sales, compared to $10.7 million, or 24.3% of net sales, in the prior year period. The decreases in Gross Profit, Adjusted Gross Profit⁽¹⁾, Gross Profit Margin, and Adjusted Gross Profit Margin⁽¹⁾ were primarily due to lower net sales and lower manufacturing production volumes.

Selling, general and administrative (“SG&A”) expense improved to $16.4 million, compared to $17.6 million in the prior year period, and Adjusted SG&A⁽¹⁾ expense improved to $9.9 million compared to $10.7 million in the prior year period. The reductions were mainly due to decreases in compensation costs from lower headcount and performance bonus, and facility costs, primarily driven by the Company's restructuring actions and related cost-saving initiatives.

Net loss was $16.4 million, or $(3.51) per diluted share, compared to net loss of $13.1 million, or $(2.86) per diluted share in the prior year period. Net loss was negatively impacted by lower net sales and gross profit, partially offset by current year SG&A expense reductions.

Adjusted EBITDA⁽¹⁾ decreased to $(4.4) million, compared to less than $0.1 million in the prior year period. The reduction was related to lower net sales and lower Adjusted Gross Profit Margin⁽¹⁾, partially offset by Adjusted SG&A⁽¹⁾ expense reductions.

Balance Sheet, Liquidity and Cash Flow

As of September 30, 2025, the Company had $10.7 million in cash and approximately $4 million of available borrowing capacity on its Revolving Credit Facility. The Company ended the third quarter with $114.5 million in principal balance outstanding on its Term Loan, $8.0 million in finance leases, and $0.1 million in other debt outstanding. During 2025 and 2024, the Company maintained a zero balance on its Revolving Credit Facility. As of September 30, 2025, the Company was in compliance with debt covenants under its Revolving Credit Facility and Term Loan.

Cash used in operating activities was less than $0.1 million and the Company invested $0.2 million in capital expenditures, yielding Free Cash Flow⁽¹⁾ of $(0.2) million during the three months ended September 30, 2025. Free Cash Flow⁽¹⁾ improved $5.1 million compared to the prior year third quarter due to working capital benefits including from a reduction in inventory.

Full Year 2025 Expectations

The Company is updating the following expectation for fiscal year 2025:

• Adjusted Gross Profit Margin⁽¹⁾ of approximately 20% for 2025, resulting primarily from an expectation of (i) a higher proprietary brand sales mix in the second half of 2025 compared to the first half, (ii) continued benefit from cost savings associated with prior year restructuring and related productivity initiatives, (iii) incremental cost savings expected from the new restructuring plan and related cost savings initiatives, and (iv) minimal non-restructuring inventory reserves or related charges.
  

The Company is reaffirming the following expectations for fiscal year 2025:

• Reduced year-over-year Adjusted SG&A⁽¹⁾ expense, consistent with previous expectations, resulting from a full year benefit of reductions completed in 2024 as well as incremental expense savings expected in the second half of 2025 related to the new restructuring and cost savings initiatives, including compensation savings, and further reductions in professional and outside service fees, facilities and insurance expense.
• Reduction in inventory and positive free cash flow for the final nine months of 2025, consistent with previous expectations.
• High tariffs on imported products from China or other countries, or new tariffs from other countries, could impact the cost of certain products and may negatively impact the Company's financial performance.
• Capital expenditures of less than $2 million for full year 2025, consistent with previous expectations.

Hydrofarm remains committed to its strategic priorities: drive diverse high-quality revenue streams, improve profit margins and strengthen financial position.

^{(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.}

Prepared Remarks and Presentation

Prepared remarks from management regarding quarterly performance and other business matters, and an earnings presentation for reference, have been made available on the Company’s investor relations website at https://investors.hydrofarm.com/. 

About Hydrofarm Holdings Group, Inc.

Hydrofarm is a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative proprietary branded products. For over 40 years, Hydrofarm has helped growers make growing easier and more productive. The Company’s mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency and speed in their grow projects.

Cautionary Note Regarding Forward-Looking Statements

Statements contained in this press release, other than statements of historical fact, which address activities, events and developments that the Company expects or anticipates will or may occur in the future, including, but not limited to, information regarding the future economic performance and financial condition of the Company, the plans and objectives of the Company’s management, and the Company’s assumptions regarding such performance and plans are “forward-looking statements” within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. These forward-looking statements generally can be identified as statements that include phrases such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” or other similar words or phrases. Actual results could differ materially from the forward-looking information in this release due to a variety of factors, including, but not limited to:

The market in which the Company operates has been substantially adversely impacted by conditions of the agricultural and cannabis industries, including oversupply and decreasing prices of the products the Company's end customers sell, which, in turn, has materially adversely impacted the Company's sales and other results of operations and which may continue to do so in the future; If industry conditions worsen or are sustained for a lengthy period, the Company could be forced to take additional impairment charges and/or inventory and accounts receivable reserves, which could be substantial, and, ultimately, the Company may face liquidity challenges; The Company’s Revolving Credit Facility and future debt facilities may limit the operation of the Company’s business including restricting its ability to sell products directly to the cannabis industry; Although equity financing may be available, the Company's current stock prices are at depressed levels and any such financing would be dilutive; Interruptions in the Company's supply chain could adversely impact expected sales growth and operations; Increased prices and inflation could adversely impact the Company's performance and financial results; Global political and economic conditions including the imposition of potential tariffs could increase the costs of the Company's products and adversely impact the competitiveness of the Company's products and the Company's financial results; The Company may be unable to meet the continued listing standards of Nasdaq; The Company's ability to effectively transition the Chief Executive Officer role and facilitate the continued succession of the Company's leadership; The Company's restructuring activities may increase our expenses and cash expenditures, and may not have the intended cost saving effects; The highly competitive nature of the Company’s markets could adversely affect its ability to maintain or grow revenues; Certain of the Company’s products may be purchased for use in new or emerging industries or segments, including the cannabis industry, and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative and enforcement approaches, and consumer perceptions which may adversely impact the market for the Company’s products; The market for the Company’s products has been impacted by conditions impacting its customers, including related crop prices, climate change, and other factors impacting growers; Compliance with government laws and regulations including environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase the Company’s costs of doing business or limit the Company’s ability to market all of its products; Damage to the Company’s reputation or the reputation of its products or products it markets on behalf of third parties could have an adverse effect on its business; If the Company is unable to effectively execute its e-commerce business, its reputation and operating results may be harmed; The Company’s operations may be impaired if its information technology systems fail to perform adequately or if it is the subject of a data breach or cyber-attack; The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to the Company’s business; Acquisitions, other strategic alliances and investments could result in operating and integration difficulties, dilution and other harmful consequences that may adversely impact the Company’s business and results of operations. Additional detailed information concerning a number of the important factors that could cause actual results to differ materially from the forward-looking information contained in this release is readily available in the Company’s annual, quarterly and other reports. The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments except as otherwise required by law.

Contacts:
Investor Contact
Anna Kate Heller / ICR
ir@hydrofarm.com

Hydrofarm Holdings Group, Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In thousands, except share and per share amounts)
		Three months ended September 30,								Nine months ended September 30,
			2025				2024				2025				2024
Net sales		$	29,350			$	44,009			$	109,129			$	152,974
Cost of goods sold			25,941				35,490				96,049				122,679
Gross profit			3,409				8,519				13,080				30,295
Operating expenses:
Selling, general and administrative			16,365				17,556				50,368				55,836
Loss on asset disposition			—				—				—				11,520
Loss from operations			(12,956	)			(9,037	)			(37,288	)			(37,061	)
Interest expense			(3,331	)			(3,910	)			(10,099	)			(11,652	)
Other income (expense), net			22				80				(140	)			374
Loss before tax			(16,265	)			(12,867	)			(47,527	)			(48,339	)
Income tax expense			(125	)			(279	)			(109	)			(865	)
Net loss		$	(16,390	)		$	(13,146	)		$	(47,636	)		$	(49,204	)
Net loss per share(1):
Basic		$	(3.51	)		$	(2.86	)		$	(10.26	)		$	(10.71	)
Diluted		$	(3.51	)		$	(2.86	)		$	(10.26	)		$	(10.71	)
Weighted-average shares of common stock outstanding(1):
Basic			4,663,422				4,603,306				4,641,522				4,594,116
Diluted			4,663,422				4,603,306				4,641,522				4,594,116
(1)Net loss per share and Weighted-average shares of common stock outstanding amounts have been adjusted to give retroactive effect to the 1-for-10 reverse stock split effected on February 12, 2025.

Hydrofarm Holdings Group, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share and per share amounts)
		September 30, 2025				December 31, 2024
Assets		​				​
Current assets:		​				​
Cash and cash equivalents		$	10,652			$	26,111
Accounts receivable, net			10,008				14,756
Inventories			38,338				50,633
Prepaid expenses and other current assets			3,628				3,712
Total current assets			62,626				95,212
Property, plant and equipment, net			34,751				37,545
Operating lease right-of-use assets			39,553				42,869
Intangible assets, net			231,196				249,002
Other assets			1,556				1,476
Total assets		$	369,682			$	426,104
Liabilities and stockholders’ equity		​				​
Current liabilities:
Accounts payable		$	11,806			$	12,279
Accrued expenses and other current liabilities			7,555				10,647
Deferred revenue			2,608				2,611
Current portion of operating lease liabilities			7,676				7,731
Current portion of finance lease liabilities			459				459
Current portion of long-term debt			40				1,260
Total current liabilities			30,144				34,987
Long-term operating lease liabilities			34,508				37,553
Long-term finance lease liabilities			7,493				7,830
Long-term debt			111,740				114,693
Deferred tax liabilities			2,952				3,047
Other long-term liabilities			4,563				4,272
Total liabilities			191,400				202,382
Commitments and contingencies		​				​
Stockholders’ equity		​				​
Common stock ($0.0001 par value; 300,000,000 shares authorized; 4,667,004 and 4,614,279 shares issued and outstanding at September 30, 2025, and December 31, 2024, respectively)(1)			—				—
Additional paid-in capital			791,012				790,094
Accumulated other comprehensive loss			(7,633	)			(8,911	)
Accumulated deficit			(605,097	)			(557,461	)
Total stockholders’ equity			178,282				223,722
Total liabilities and stockholders’ equity		$	369,682			$	426,104
(1)Shares issued and outstanding have been adjusted to give retroactive effect to the 1-for-10 reverse stock split effected on February 12, 2025.

Hydrofarm Holdings Group, Inc. RECONCILIATION OF NON-GAAP MEASURES (In thousands, except share and per share amounts) (Unaudited)
		Three months ended September 30,								Nine months ended September 30,
			2025				2024				2025				2024
Reconciliation of Adjusted Gross Profit:
Gross Profit (GAAP)		$	3,409			$	8,519			$	13,080			$	30,295
Depreciation, depletion and amortization			1,346				1,603				4,075				4,860
Restructuring expenses1			753				577				4,416				1,558
Adjusted Gross Profit (Non-GAAP)		$	5,508			$	10,699			$	21,571			$	36,713
As a percent of net sales:
Gross Profit Margin (GAAP)			11.6	%			19.4	%			12.0	%			19.8	%
Adjusted Gross Profit Margin (Non-GAAP)			18.8	%			24.3	%			19.8	%			24.0	%

		Three months ended September 30,								Nine months ended September 30,
			2025				2024				2025				2024
Reconciliation of Adjusted SG&A:
Selling, general and administrative (GAAP)		$	16,365			$	17,556			$	50,368			$	55,836
Depreciation, depletion and amortization			5,990				6,060				17,982				18,464
Restructuring expenses1			142				79				162				163
Severance and other2			130				69				359				264
Stock-based compensation3			207				669				971				2,306
Acquisition and integration expenses4			10				—				225				—
Adjusted SG&A (Non-GAAP)		$	9,886			$	10,679			$	30,669			$	34,639
As a percent of net sales:
SG&A (GAAP)			55.8	%			39.9	%			46.2	%			36.5	%
Adjusted SG&A (Non-GAAP)			33.7	%			24.3	%			28.1	%			22.6	%

		Three months ended September 30,								Nine months ended September 30,
			2025				2024				2025				2024
Reconciliation of Adjusted EBITDA:
Net loss (GAAP)		$	(16,390	)		$	(13,146	)		$	(47,636	)		$	(49,204	)
Interest expense			3,331				3,910				10,099				11,652
Income tax expense			125				279				109				865
Depreciation, depletion and amortization			7,336				7,663				22,057				23,324
Restructuring expenses1			895				656				4,578				1,721
Severance and other2			130				69				359				264
Stock-based compensation3			207				669				971				2,306
Acquisition and integration expenses4			10				—				225				—
Other expense (income), net5			(22	)			(80	)			140				(374	)
Loss on asset disposition6			—				—				—				11,520
Adjusted EBITDA (Non-GAAP)		$	(4,378	)		$	20			$	(9,098	)		$	2,074
As a percent of net sales:
Net loss (GAAP)		(55.8)%				(29.9)%				(43.7)%				(32.2)%
Adjusted EBITDA (Non-GAAP)		(14.9)%					0.0	%		(8.3)%					1.4	%

		Three months ended September 30,								Nine months ended September 30,
			2025				2024				2025				2024
Reconciliation of Free Cash Flow:
Net cash used in operating activities (GAAP):		$	(37	)		$	(4,467	)		$	(10,084	)		$	(2,980	)
Capital expenditures of Property, plant and equipment (GAAP)			(170	)			(812	)			(695	)			(2,622	)
Free Cash Flow (Non-GAAP):		$	(207	)		$	(5,279	)		$	(10,779	)		$	(5,602	)

Notes to GAAP to Non-GAAP reconciliations presented above (Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA, and Free Cash Flow):

1. For the three and nine months ended September 30, 2025, Restructuring expenses primarily related to non-cash inventory markdowns, and cash charges incurred to relocate and terminate certain facilities. For the three and nine months ended September 30, 2024, Restructuring expenses related primarily to manufacturing facility consolidations, and the charges incurred to relocate and terminate certain facilities.
2. For the three months ended September 30, 2025, Severance and other charges was primarily comprised of certain legal charges. For the nine months ended September 30, 2025, Severance and other charges also included legal costs related to the 1-for-10 reverse stock split effected on February 12, 2025. For the nine months ended September 30, 2024, Severance and other charges primarily related to estimated legal costs related to certain litigation and severance charges.
3. Includes stock-based compensation and related employer payroll taxes on stock-based compensation for the periods presented.
4. For the three and nine months ended September 30, 2025, Acquisition and integration expenses includes consulting, transaction services and legal fees for potential acquisitions, divestitures, or strategic combinations.
5. For the nine months ended September 30, 2025, Other expense (income), net related primarily to a loss on debt extinguishment recorded in conjunction with the Term Loan prepayment.
6. Loss on asset disposition for the nine months ended September 30, 2024, relates to the loss on the sale of assets relating to the production of Innovative Growers Equipment durable equipment products (the "IGE Asset Sale").

Non-GAAP Financial Measures

We report our financial results in accordance with generally accepted accounting principles in the U.S. (“GAAP”). Management believes that certain non-GAAP financial measures provide investors with additional useful information in evaluating our performance and that excluding certain items that may vary substantially in frequency and magnitude period-to-period from net loss provides useful supplemental measures that assist in evaluating our ability to generate earnings and to more readily compare these metrics between past and future periods. These non-GAAP financial measures may be different than similarly titled measures used by other companies.

To supplement our condensed consolidated financial statements which are prepared in accordance with GAAP, we use "Adjusted EBITDA", "Adjusted Gross Profit", "Adjusted SG&A", "Free Cash Flow", "Net Debt", and "Liquidity" which are non-GAAP financial measures. We also present certain of these non-GAAP metrics as a percentage of net sales. Our non-GAAP financial measures should not be considered in isolation from, or as substitutes for, financial information prepared in accordance with GAAP. There are several limitations related to the use of our non-GAAP financial measures as compared to the closest comparable GAAP measures.

We define Adjusted EBITDA (non-GAAP) as net loss (GAAP) excluding interest expense, income taxes, depreciation, depletion and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, impairments, severance, loss on asset disposition, other income/expense, net, and other non-cash, unusual and/or infrequent costs (i.e., acquisition and integration expenses), which we do not consider in our evaluation of ongoing operating performance.

We define Adjusted EBITDA (non-GAAP) as a percent of net sales as Adjusted EBITDA (as defined above) divided by net sales in the respective period.

We define Adjusted Gross Profit (non-GAAP) as Gross Profit (GAAP) excluding depreciation, depletion, and amortization, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs, which we do not consider in our evaluation of ongoing operating performance.

We define Adjusted Gross Profit Margin (non-GAAP) as a percent of net sales as Adjusted Gross Profit (as defined above) divided by net sales in the respective period.

We define Adjusted SG&A (non-GAAP) as SG&A (GAAP) excluding depreciation, depletion, and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs (i.e., acquisition and integration expenses), which we do not consider in our evaluation of ongoing operating performance.

We define Adjusted SG&A (non-GAAP) as a percent of net sales as Adjusted SG&A (as defined above) divided by net sales in the respective period.

We define Free Cash Flow (non-GAAP) as Net cash from (used in) operating activities less capital expenditures for property, plant and equipment. We believe this provides additional insight into the Company's ability to generate cash and maintain liquidity. However, Free Cash Flow does not represent funds available for investment or other discretionary uses since it does not deduct cash used to service our debt or other cash flows from financing activities or investing activities.

We define Liquidity as total cash, cash equivalents and restricted cash, if applicable, plus available borrowing capacity on our Revolving Credit Facility.

We define Net Debt as total debt principal outstanding plus finance lease liabilities and other debt, less cash, cash equivalents and restricted cash, if applicable.

FAQ

What were Hydrofarm's Q3 2025 net sales and year-over-year change (HYFM)?

Hydrofarm reported Q3 2025 net sales of $29.4M, a 33.3% decline versus the prior year period.

How much did Hydrofarm (HYFM) lose in Q3 2025 and what was adjusted EBITDA?

Net loss for Q3 2025 was $16.4M (diluted $(3.51)); adjusted EBITDA was $(4.4)M.

When does Bill Toler become Hydrofarm CEO and who is he replacing (HYFM)?

Bill Toler resumes the CEO role effective December 1, 2025, replacing John Lindeman who will remain through that date.

What cost savings did Hydrofarm (HYFM) announce in the Q3 2025 release?

The company expects an incremental $2M annual savings from U.S. facility consolidation and identified an additional $4M of annual savings in view.

What is Hydrofarm's cash and debt position at Sept 30, 2025 (HYFM)?

As of Sept 30, 2025 Hydrofarm had $10.7M cash, ~$4M revolver availability, and $114.5M term loan principal outstanding.

What full‑year 2025 guidance did Hydrofarm (HYFM) provide for margins and capex?

Hydrofarm expects full‑year 2025 adjusted gross profit margin of about 20% and capital expenditures of less than $2M.